IAIM
VIR icon

International Assets Investment Management’s Vir Biotechnology VIR Stock Holding History

International Assets Investment Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-330
Closed -$9K – 1851
2021
Q1 		$9K Hold
330
– – ﹤0.01% 1614
2020
Q4 		$9K Buy
+330
New +$10.7K ﹤0.01% 1477

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

International Assets Investment Management's VIR Position: Q2 2021 in Review

International Assets Investment Management sold out of Vir Biotechnology (VIR) in Q2 2021, closing a stake of 330 shares — an estimated $9K sold.

International Assets Investment Management first reported a position in VIR in Q4 2020 and held it in 2 quarters. The position peaked at $9K in Q1 2021. 165 funds tracked by Wall St. Rank hold VIR as of Q2 2021.

  • International Assets Investment Management reported no remaining Vir Biotechnology position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 330 Vir Biotechnology shares in Q2 2021, an estimated $9K.
  • International Assets Investment Management first reported a position in Vir Biotechnology in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Vir Biotechnology position peaked at $9K in Q1 2021.
  • 165 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.